Form 4 for ISRG Intuitive Surgical
Accepted 2025-10-27 00:00:00 ET · period of report 2025-10-24 · accession 0001280628-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-27 | 2025-10-24 | ISRG | GUTHART GARY S | Executive COB of the Board o, Dir | S - Sale+OE | $547.56 | -28.8K | 27.0K | -52% | -$15.77M |
| D | 2025-10-27 | 2025-10-24 | ISRG | GUTHART GARY S | Executive COB of the Board o, Dir | M - OptEx | $109.49 | +36.0K | 55.8K | +182% | +$3.94M |
| DMI | 2025-10-27 | 2025-10-24 | ISRG | GUTHART GARY S | Executive COB of the Board o, Dir | S - Sale+OE | $546.26 | -2,800 | 17.1K | -14% | -$1.53M |
| D | 2025-10-27 | 2025-10-24 | ISRG | GUTHART GARY S | Executive COB of the Board o, Dir | M - OptEx | $0.00 | -36.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-10-24 | S | D | 28,800 | $547.56 | 27,027 | D Trust FBO Son | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $541.76 to $550.16 as follows: 800 shares sold at $541.76 to $542.59; 1,000 shares sold at $542.89 to $543.22; 2,563 shares sold at $544 to $545; 1,600 shares sold at $545.33 to $546.29; 2,770 shares sold at $546.34 to $547.19; 7,383 shares sold at $547.35 to $548.31; 9,068 shares sold at $548.36 to $549.35; and 3,616 shares sold at $549.485 to $550.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-10-24 | M | A | 36,000 | $109.49 | 55,827 | D Trust FBO Daughter | — | — | |
| 3 | Common | Common Stock | 2025-10-24 | S | D | 1,400 | $546.18 | 17,120 | I | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.16 to $548.45 as follows: 190 shares sold at $542.16 to $542.98; 150 shares sold at $543.79 to $544.30; 190 shares sold at $545.00 to $545.33; 292 shares sold at $546.34 to $547.20; and 578 shares sold at $547.51 to $548.45. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2025-10-24 | S | D | 1,400 | $546.35 | 17,120 | I | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $542.74 to $548.48 as follows: 100 shares sold at $542.74; 205 shares sold at $543.97 to $544.45; 250 shares sold at $545.06 to $545.94; 200 shares sold at $546.46 to $546.75; and 645 shares sold at $547.49 to $548.48. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-10-24 | M | D | 36,000 | $0.00 | 0 | D | $109.49 · — to 2027-08-15 | 36,000 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |